DA
Donald A Bergstrom sold $162K of RLAY stock
Donald A Bergstrom, President, R&D of Relay Therapeutics, Inc. (RLAY), sold 8,530 shares of RLAY stock worth $162K, per an SEC Form 4 filed Sep 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 8, 2026, 1 day before it was made public.
RLAY has moved -15.6% since the trade date, from $19.11 to $16.12 (Nov 20, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 1 day
- Price since
- -15.6%
- Role
- President, R&D
- Source
- SEC Form 4